ROBERTO BAYLON DELA CRUZ JR.

Allopathic & Osteopathic Physicians|Family Medicine RICHARDSON, TX NPI 1912101577

General Payments — all program years on this page

$822.00

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 45
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $370.53 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $370.5320

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $143.398
Lilly USA, LLC $65.134
Boehringer Ingelheim Pharmaceuticals, Inc. $48.462
Exact Sciences Corporation $36.592
EISAI INC. $22.891
PFIZER INC. $21.051
Acerta Pharma LLC $17.971
ABBVIE INC. $15.051

By program year

Program yearAmountRecords
2018 $437.2924
2023 $14.181
2024 $370.5320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096672447 Novo Nordisk Inc $15.91 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096776147 Novo Nordisk Inc $21.53 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096805172 Novo Nordisk Inc $18.07 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096816610 Novo Nordisk Inc $14.57 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096858372 Novo Nordisk Inc $18.11 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097051212 Novo Nordisk Inc $22.90 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097403226 Novo Nordisk Inc $15.15 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097829150 Novo Nordisk Inc $17.15 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103620548 ABBVIE INC. $15.05 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105874859 AstraZeneca Pharmaceuticals LP $17.97 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110777369 Eisai Inc. $22.89 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114631967 Exact Sciences Corporation $14.29 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114631972 Exact Sciences Corporation $22.30 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118231026 Boehringer Ingelheim Pharmaceuticals, Inc. $23.19 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118231028 Boehringer Ingelheim Pharmaceuticals, Inc. $25.27 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131030922 PFIZER INC. $21.05 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135337729 Lilly USA, LLC $18.82 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135357065 Lilly USA, LLC $15.20 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135372144 Lilly USA, LLC $13.91 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135398739 Lilly USA, LLC $17.20 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.